Qlibrium - Crunchbase Company Profile & Funding

Q: Where is Qlibrium's headquarters?

Qlibrium is located in Woburn, Massachusetts, United States.

Overview

Qlibrium

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Qlibrium

CB Rank

522836

Qlibrium is a provider of on‑body drug delivery systems.

Founded

obfuscation

Private

Woburn, Massachusetts, United States

51-100

www.qlibriumlabs.com

Health Care

Medical

Personal Health

Wearables

Details

Legal Name

Qlibrium

Operating Status

Active

Company Type

For Profit

About the Company

Qlibrium develops electrochemical and microfluidic technology platforms for on-body delivery systems for pharmaceutical companies and patients. They create user acceptance and improve compliance, thereby helping patients with a simple click and meeting their need for ease of use and livability.

Phone Number

+1 781 287 9265

Contact Email

careers@qlibriumlabs.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

QForma

A wearable insulin delivery system that features a low-profile pump, allowing for discreet and comfortable insulin administration controlled via a mobile device.

QLib OBDS

A platform for on-body delivery of injectable drugs, designed to be thin and flexible, accommodating various drug volumes and viscosities for improved patient compliance.